Table 1 Patient characteristics

Characteristics	No. of patients
No. of patients enrolled	45
Age (years)
Median	59
Range	36–78
Sex
Male	23
Female	22
ECOG performance status
0	19
1	22
2	4
Histologic type
Adenocarcinoma (well and moderately differentiated)	21
Poorly differentiated adenocarcinoma	9
Squamous cell carcinoma	7
Poorly differentiated carcinoma	5
Clear cell carcinoma	1
Small cell carcinoma	1
Undifferentiated carcinoma	1
No. of disease sites
1	13
2	10
⩾3	22
Site of disease
Lymph node	40
Lung	6
Bone	4
Liver	8
Adrenal	2
Malignant effusion	4
Soft tissue	3
Other	6
Prognostic index
Culine et al (2002a) ^a
Good risk	29
Poor risk	16
van der Gaast et al (1996) ^b
Good risk	19
Intermediate risk	19
Poor risk	7

ECOG=Eastern Cooperative Oncology Group.
^aGood-risk patients had a performance status of 0 or 1 and normal serum lactate dehydrogenase (LDH) levels; poor-risk patients had a performance status of ⩾2 or elevated serum LDH levels.
^bGood-risk patients had a performance status of 0 and serum alkaline phosphatase (ALP) levels of <1.25 × normal range (N); intermediate-risk patients had a performance status of ⩾1 or serum ALP levels of ⩾1.25 × N; poor-risk patients had a performance status of ⩾1 and serum ALP levels of ⩾1.25 × N.

Quick links

Search